News

Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of ...
Cancer survival has doubled in the past half a century, but around 167,000 people still die of the disease in the UK every ...
According to Research by SNS Insider, U.S. Multiple Myeloma Market is projected to reach USD 13.91 Billion by 2032, as novel drug classes, immunotherapies, and diagnostic advances reshape treatment ...
"My dad passed away in December 2020, and it was sudden - he was diagnosed with cancer and was gone within three weeks. I ...
"I think they signed me off for two or three weeks and started me on antidepressants. You take the advice that's given, and I ...
A woman has spoken out about her ordeal, claiming she felt as though she was "going insane" after doctors misdiagnosed her ...
Meta: In July of 2025, the U.S. Food and Drug Administration approved various anti-cancer treatments and therapeutic ...
New FDA approvals in July include therapies for NSCLC, relapsed multiple myeloma, liver cancer, and B-cell malignancies.
The first commercial for Johnson & Johnson and Legend Biotech’s Carvykti focuses on the numbers that make up a multiple ...
As July concludes, the landscape of hematologic oncology continues to evolve, with notable progress in multiple myeloma, ...
Dar es Salaam. It was a journey marked by pain, resilience and deep reflection. That is how veteran politician Prof Mark Mwandosya describes his year-long battle with multiple myeloma, a rare form of ...